Navigating Intimacy: Understanding the Impact of HPV on Relationships

Navigating Intimacy: Understanding the Impact of HPV on Relationships

Human Papillomavirus (HPV) belongs to a group of viruses that mainly affect the skin and the moist lining (mucous membranes) inside certain parts of the body. It is a very common sexually transmitted infection (STI), spreading principally through close skin-to-skin genital contact, as well as during vaginal, anal, or oral sex in both men and women1. More than 200 different HPV subtypes are recognised, and are classed as either high risk or low risk according to their risk of causing the development of cancer2

Can HPV ruin a relationship?

Discovering an HPV infection in a relationship can evoke a multitude of fears and uncertainties3, from questioning how the virus was contracted to navigating the conversation about disclosing the infection to your partner.

The presence of HPV can definitely introduce new dynamics between the couple, potentially causing emotional strain4. However, the impact tends to vary depending on several factors such as communication, emotional resilience, and the specific details surrounding the infection. Importantly, having HPV does not necessarily ruin a relationship with a partner; many couples successfully overcome challenges and maintain healthy, fulfilling relationships.

Regardless of whether HPV can disrupt a relationship, it is important to be aware of the following aspects that relate to the presence of infection between couples:

Disclosure: To alleviate concerns and effectively address any physical or emotional repercussions upon discovering an HPV infection, open communication about HPV and its associated risks are imperative for fostering trust and transparency within the relationship.

Impact on intimacy: Despite being HPV-positive, you can maintain a regular sexual life in a relationship. However, it is essential to communicate openly with your partner about your diagnosis and take appropriate precautions to reduce the risk of transmission, while prioritising the physical and emotional wellbeing of both partners. 

Health monitoring: Routine health check ups, in addition to regular cervical screening for women and people with a cervix, are extremely important for cancer prevention. Even if vaccinated against HPV, eligible individuals must still undergo cervical screening because it plays a crucial role in the early detection and treatment of HPV-related cervical cell changes that could possibly become cancerous, mitigating the risk of potential health complications.

How to handle HPV in a relationship

HPV is not treatable itself. Typically, the immune system clears an HPV infection within a period of two years. However, in some instances, that does not happen for some unknown reasons. As a result, the virus can remain in the body for a prolonged period leading to a ‘persistent HPV infection’. This can potentially cause the development of certain types of cancer if remained undetected or untreated5.

To effectively manage and prevent HPV infections, it is crucial to be well-informed about the virus and its health implications. When entering a relationship with an HPV-positive partner, it is essential to make informed decisions regarding your sexual health, including the adoption of safe sexual practices. Additionally, having an approach that prioritises overall health is vital; preventative measures such as HPV vaccination and regular cervical screening are crucial for better health outcomes.

The HPV vaccine is highly effective against the most common high-risk types that could cause HPV-related cancers such as cervical, vaginal, vulval, anal, penile, and oropharyngeal cancers. The HPV vaccine also offers protection against certain low-risk HPV types that could cause genital warts. It is important to note that the HPV vaccine does not treat existing HPV infections; its efficacy is highest when administered prior to exposure to the virus. This means that if your partner is already infected with HPV, vaccination will not eradicate the virus but can offer some protection if you are HPV-negative. Given that the HPV vaccine does not provide immunity against all cancer-associated high-risk HPV types, it is imperative to adopt supplementary measures for a comprehensive cancer prevention strategy; this is particularly relevant for cervical cancer prevention6.

10zyme: Reimagining women’s health

10zyme is improving cervical screening with a groundbreaking test designed to enhance your experience and put you in control of your cervical health.

Our at-home test AND results kit will be easy-to-use, reliable, and non-invasive, enabling you to conveniently screen for HPV infections that cause cervical cancer in the comfort and privacy of your home, with results available in just minutes.

At 10zyme, our goal is to create a positive change in women’s health. With our innovative diagnostic test, you will be able to proactively manage your health by providing better access to vital preventative measures against cancer.

Explore our website to discover more about our cutting-edge mission, and visit 10zyme’s Education Station to learn more about Human Papillomavirus (HPV) and the associated health conditions, including cervical cancer and other related types of cancer, through our diverse range of engaging and informative blogs, articles, and free downloadable guides dedicated to equipping you with essential knowledge that will help effectively guide your prevention strategy.

Also, follow us for the latest news, events, and updates on our social channels: LinkedIn, Instagram, and TikTok.


  1. National Health Service (NHS). (2022). Human Papillomavirus. (Online). Available at: [Accessed 23/04/2024]
  2. Cancer Research UK (CRUK). (2024). Does HPV cause cancer? (Online). Available at: [Accessed 23/04/2024]
  3. Macmillan Cancer Support. (2021). Human papilloma virus. (Online). Available at: [Accessed 23/04/2024]
  4. Jo’s Cervical Cancer Trust. (2024). Dating and HPV. (Online). Available at: [Accessed 23/04/2024]
  5. Cancer Research UK (CRUK). (2019). Cervical cancer risk. (Online). Available at: [Accessed 23/04/2024]
  6. Choi S. et al. (2023). HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK. PubMed Central (PMC). 12(2):298. [Online]. Available at: [Accessed 23/04/2024]

Leave a Reply

Your email address will not be published. Required fields are marked *